Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    -0.005 (-2.63%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Total Voting Rights

31 Dec 2012 07:00

RNS Number : 4844U
ValiRx PLC
31 December 2012
 



31 December 2012

VALIRX PLC

("ValiRx" or the "Company")

 

Total Voting Rights

 

In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 1,711,184,409 ordinary shares of 0.1p each in issue, each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.

 

The above figure of 1,711,184,409 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

 

Enquires

ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr Satu Vainikka

www.ValiRx.com

Nominated Adviser

Cairn Financial Advisers LLP

 

Tel:+44 (0) 20 7148 7900

Liam Murray / Avi Robinson

Broker

Hybridan LLP

 

Tel: +44 (0) 20 7947 4350

Claire Noyce / Deepak Reddy

Peckwater PR

Tel: +44 (0)7879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREALAPAASAFFF
Date   Source Headline
11th Oct 20127:00 amRNSre: UK Distribution Agreement
20th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSVAL201 Update re: Breast Cancer Study
2nd Aug 20127:00 amRNSRe: GeneICE and Biomarkers Development Update
29th May 201211:07 amRNSResult of AGM
29th May 20127:00 amRNSUpdate re: Late Pre-clinical Study of VAL201
15th May 20127:00 amRNSNew US Patent Grant
27th Apr 20127:00 amRNSFinal Results
2nd Apr 201212:17 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSPlacing of GBP 900,000 and Director's Dealing
29th Mar 20127:00 amRNSRe Agreement
8th Mar 20127:00 amRNSPeer Review Findings Published re VAL201
14th Feb 20127:00 amRNSEstablishment of Scientific & Advisory Board
2nd Feb 20127:00 amRNSNew European Patent Grant
31st Jan 201210:14 amRNSTotal Voting Rights
5th Jan 20127:00 amRNSAcquisition
15th Dec 20117:00 amRNSNew Patent Grant for GeneICE & VAL101 Update
9th Dec 20114:23 pmRNSRe Volition - Allotment of Shares
24th Nov 20117:00 amRNSHolding(s) in Company
3rd Nov 20117:00 amRNSNew Patent Filing
7th Oct 20118:00 amRNSVolition Update
27th Sep 20117:00 amRNSVolition Update
22nd Sep 20117:00 amRNSHalf Yearly Report
8th Sep 20117:00 amRNSDistribution Agreement
18th Aug 20117:00 amRNSAcquisition of Finnish Non-Trading Company
28th Jul 20117:00 amRNSVAL201 Update
19th Jul 20113:59 pmRNSHolding(s) in Company
14th Jul 20117:00 amRNSDirector/PDMR Shareholding
11th Jul 20117:00 amRNSGrant of Options
23rd Jun 201110:55 amRNSResult of AGM
23rd Jun 20117:00 amRNSAGM Statement
21st Jun 20117:00 amRNSGeneICE Update
10th Jun 20117:00 amRNSVolition - update
2nd Jun 20117:00 amRNSDirectorate Change
31st May 20111:30 pmRNSPublication of Report & Accounts and Notice of AGM
31st May 20117:00 amRNSTotal Voting Rights
31st May 20117:00 amRNSFinal Results
26th May 20112:56 pmRNSHolding(s) in Company
20th May 20117:00 amRNSWebsite update
14th Apr 20117:00 amRNSAgreements with Imperial College & Oxford Uni
9th Mar 20112:54 pmRNSHolding(s) in Company
9th Mar 201111:15 amRNSHolding(s) in Company
7th Mar 201110:56 amRNSResult of EGM
7th Mar 20117:00 amRNSStatement re General Meeting
25th Feb 20112:09 pmRNSWebsite Update
18th Feb 20112:54 pmRNSPublication of Circular and Notice of GM
16th Feb 20117:19 amRNSIssue of Equity
14th Feb 20117:00 amRNSUpdate
1st Feb 201111:38 amRNSTotal Voting Rights
31st Jan 20117:00 amRNSFurther re Sale of Belgian Subsidiary, ValiBIO SA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.